St. Jude Clinical Trials
Non-therapeutic study examining the feasibility, acceptance and impact of clinical WGS, WES and RNA sequencing in a pediatric oncology setting
This is a non-therapeutic clinical trial that is open to new St. Jude patients. The patient has:
- cancerous or non-cancerous tumor that has been newly diagnosed
- recurred after previous treatment
- not responded to previous treatment (refractory disease)
The protocol is also open to current St. Jude patients with recurrent or refractory disease, where biopsy or resection is being performed to establish the diagnosis and/or palliate symptoms.
This is a non-therapeutic clinical trial open to St. Jude patients only.
Participants have been pre-identified by the primary care team as an English-speaking, four-member family unit diagnosed with TP53 mutation.
This is a non-therapeutic clinical trial that is only open to St. Jude patients
Familial Investigations of Childhood Cancer Predisposition
Non-therapeutic clinical trial
This is a non-therapeutic clinical trial that is open to children and adults with familial cancer and to their eligible family members.
In this research study, the definition of “Familial Cancer” is met if any of the following is present:
- An individual and at least one first, second or third degree relative, each with a history of cancer diagnosed under 50 years of age; OR
- An individual under 50 years of age with more than one cancers; OR
- An individual with a clinical or molecular diagnosis of a known cancer predisposition syndrome
Eligible individuals include:
- An individual who meets the definition of “Familial Cancer,” as above
- Blood relatives of the above individual with familial cancer, who are affected or unaffected by cancer